Jules has spent over 30 years working in the deep tech space internationally, initially with corporates such as Eli Lilly (UK) and Genzyme (US). She has significant experience in commercialisation at the intersection of science, technology and market opportunity, working with Kiwi start-ups and the next generation of entrepreneurs.

Her professional passions include helping high-growth technology companies and innovative businesses to thrive on the global stage and investing in the future of a diversified New Zealand economy through nurturing start-ups and the next generation of world-class entrepreneurs.

Jules also holds an MBA from Alliance Manchester Business School (UK), where she was a longstanding mentor on the full-time MBA programme. She is also a mentor on the University of Auckland Business School Women’s Mentoring Programme and a founding member of the Manawatū Momentum Investment Committee. The Momentum Programme comprises a growing number of student-led investment committees focused on start-up ventures, particularly those originating from tertiary student- and staff-owned intellectual property and technologies.

Jules is established in the New Zealand early-stage research commercialisation and start-up ecosystem.  She is Chair of the Biotech Investment Committee and was founding Chair of the MedTech Investment committee for the Return on Science programme – pre-seed investment funds that invest in commercialising technology innovations from publicly funded research. She also works with many business incubators and accelerators in an advisory, investment or mentorship capacity.